ArticleClinical cardiology2004
Anticoagulation for atrial fibrillation: underutilization in a Brazilian tertiary outpatient clinic.
Article in Clinical cardiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 10 citations in OpenAlex.
- Evaluation of Mortality in Atrial Fibrillation: Clinical Outcomes in Digital Electrocardiography (CODE) Study.Global heart · 2020Observational
- Thromboembolism and bleeding risk scores and predictors of cardiac death in a population with atrial fibrillation.Arquivos brasileiros de cardiologia · 2017Observational
- Potential use of NOACs in developing countries: pros and cons.European journal of clinical pharmacology · 2014Review
- Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation.Clinics (Sao Paulo, Brazil) · 2012Article
- Targeting stroke risk and improving outcomes in patients with atrial fibrillation in Latin America.Sao Paulo medical journal = Revista paulista de medicinaReview
Corrections and comments
- Comment on
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite a clear benefit of anticoagulation in patients with atrial fibrillation for the prevention of stroke, treatment rates are disappointingly low in clinical practice in the industrialized countries. This survey demonstrates similar rates in a Brazilian tertiary outpatient clinic, with only 55% of patients at high risk receiving dose-adjusted warfarin. Poor patient education and health care system limitations are considered important barriers. Strategies to improve treatment rates should target specific problems at each location.
Indexed as
Identifiers
15562925W2473908455What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.